Medicare Enrolled

Dr. Shamita Trivedi, D.O.

Endocrinology · Dallas, TX
12200 PARK CENTRAL DR STE 200, Dallas, TX 75251
9726852740
Registered in NPPES since 2008
NPI: 1114187903 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Trivedi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trivedi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Trivedi

Dr. Shamita Trivedi is an endocrinology specialist in Dallas, TX, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Trivedi received a total of $12,835 from 38 pharmaceutical and/or device companies across 698 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Trivedi is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration $12,835 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,835
Total received (2018-2024)
Avg $1,834/year across 7 years
Top 28% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
698
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20
2023
$1,780
2022
$2,757
2021
$2,234
2020
$1,796
2019
$4,092
2018
$156

Payments by company (2024)

Corcept Therapeutics
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Dexcom, Inc.
$2,453
Insulet Corporation
$1,794
AbbVie Inc.
$1,070
TOLMAR Pharmaceuticals, Inc.
$964
Novo Nordisk Inc
$819
Alexion Pharmaceuticals, Inc.
$718
Endo Pharmaceuticals Inc.
$643
Xeris Pharmaceuticals, Inc.
$627
ABBVIE INC.
$374
Ascendis Pharma, Inc.
$308
Embecta Corp.
$295
Lilly USA, LLC
$278
PFIZER INC.
$267
Zealand Pharma US, Inc.
$235
Amneal Pharmaceuticals LLC
$212
AbbVie, Inc.
$193
Ascendis Pharma Inc
$192
Arbor Pharmaceuticals, Inc.
$172
Tolmar, Inc.
$154
ARBOR PHARMACEUTICALS, INC.
$128
Tandem Diabetes Care, Inc.
$123
Rhythm Pharmaceuticals, Inc.
$119
Eton Pharmaceuticals, Inc.
$108
Ipsen Biopharmaceuticals, Inc
$99
Medtronic, Inc.
$99
Ultragenyx Pharmaceutical Inc.
$71
Azurity Pharmaceuticals, Inc.
$62
SANOFI-AVENTIS U.S. LLC
$40
Medtronic MiniMed, Inc.
$36
IBSA Pharma Inc.
$27
LifeScan, Inc.
$26
Companion Medical, Inc.
$22
Amryt Pharma Holdings Ltd
$22
Abbott Laboratories
$22
Corcept Therapeutics
$20
Ferring Pharmaceuticals Inc.
$16
BioMarin Pharmaceutical Inc.
$15
LIFESCAN, INC.
$12
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
ALKINDI · BAQSIMI · BD Nano 2nd Gen Pen Needle · Crysvita · Cryvista · Dexcom CGM · Dexcom G6 Transmitter · FENSOLVI · FreeStyle Libre · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · INCRELEX · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · Korlym · LUPRON DEPOT · Lupron · Lupron Depot · MINIMED 780G · MYALEPT · Minimed 670G System · Minimed 770G System · NASCOBAL · NGENLA · Norditropin · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · Ozempic · SKYTROFA · STRENSIQ · SUPPRELIN · SUPPRELIN LA · SYNTHROID · Sogroya · Strensiq · Synthroid · TZIELD · Tirosint · Tresiba · Triptodur · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · ZEGALOGUE · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Dallas?
Compare endocrinologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
103
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY GREEN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Trivedi is an endocrinology specialist, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Trivedi receive payments from pharmaceutical companies?
Yes. Dr. Trivedi received a total of $12,835 from 38 companies across 698 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Trivedi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →